YSB (HKSE:09885) Net Margin % : 0.25% (As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is YSB Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. YSB's Net Income for the six months ended in Jun. 2024 was HK$23 Mil. YSB's Revenue for the six months ended in Jun. 2024 was HK$9,489 Mil. Therefore, YSB's net margin for the quarter that ended in Jun. 2024 was 0.25%.

The historical rank and industry rank for YSB's Net Margin % or its related term are showing as below:

HKSE:09885' s Net Margin % Range Over the Past 10 Years
Min: -18.89 Med: -9.97 Max: -0.09
Current: -0.09

HKSE:09885's Net Margin % is ranked worse than
60.21% of 671 companies
in the Healthcare Providers & Services industry
Industry Median: 2.11 vs HKSE:09885: -0.09

YSB Net Margin % Historical Data

The historical data trend for YSB's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YSB Net Margin % Chart

YSB Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Net Margin %

-9.43

-4.97

-10.51

-18.89

YSB Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Net Margin %	Get a 7-Day Free Trial			-9.46	-11.44	-39.76	-0.42	0.25

Competitive Comparison of YSB's Net Margin %

For the Pharmaceutical Retailers subindustry, YSB's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

YSB's Net Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, YSB's Net Margin % distribution charts can be found below:

* The bar in red indicates where YSB's Net Margin % falls into.

YSB Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

YSB's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-3507.21	/	18563.917
	=	-18.89 %

YSB's Net Margin for the quarter that ended in Jun. 2024 is calculated as

Net Margin	=	Net Income (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	23.49	/	9488.606
	=	0.25 %

YSB (HKSE:09885) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

YSB Net Margin % Related Terms

Thank you for viewing the detailed overview of YSB's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

YSB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » YSB Inc (HKSE:09885) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8 Brand Street, No. 397 Xingang Middle Road, Yaoshibang Building, TIT Creative Industry Zone, Guangzhou, CHN

Website

https://www.ysbang.cn

YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Company is committed to using digitalization to empower participants in the out-of-hospital pharmaceutical market, including pharmaceutical companies, distributors, vendors, pharmacies and primary healthcare institutions, and strives to bring pharmaceutical health products and services to the downstream safely and efficiently, so that users can easily obtain a large number of comprehensive and high-quality drugs at a fair and transparent price. It has turned the process of pharmaceutical transaction and service into a digitalized, standardized and scalable one.

Executives

Chu Mang Yee	2201 Interest of corporation controlled by you
Meta Group Limited	2201 Interest of corporation controlled by you
Sounda Properties Limited	2201 Interest of corporation controlled by you
Shenzhen Songhe International Capital Management Partnership (limited Partnership)	2201 Interest of corporation controlled by you
Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd.	2101 Beneficial owner
Shanghai Fosun Pharmaceutical (group) Co., Ltd.	2201 Interest of corporation controlled by you
Shanghai Fosun High Technology (group) Co., Ltd.	2201 Interest of corporation controlled by you
Chen Xiaohong	2201 Interest of corporation controlled by you
H Capital V Gp, L.p.	2201 Interest of corporation controlled by you
H Capital V Gp, Ltd.	2201 Interest of corporation controlled by you
Guo Guangchang	2201 Interest of corporation controlled by you
Fosun Holdings Limited	2201 Interest of corporation controlled by you
Fosun International Holdings Ltd.	2201 Interest of corporation controlled by you
Fosun International Limited	2201 Interest of corporation controlled by you
Miyt Holdings Limited	2101 Beneficial owner

YSB Headlines

No Headlines